Cytotoxic effects and tolerability of gemcitabine and axitinib in a xenograft model for c-myc amplified medulloblastoma
出版年份 2021 全文链接
标题
Cytotoxic effects and tolerability of gemcitabine and axitinib in a xenograft model for c-myc amplified medulloblastoma
作者
关键词
-
出版物
Scientific Reports
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-07
DOI
10.1038/s41598-021-93586-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Determination of a Tumor-Promoting Microenvironment in Recurrent Medulloblastoma: A Multi-Omics Study of Cerebrospinal Fluid
- (2020) Bernd Reichl et al. Cancers
- Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
- (2020) Kyle S. Smith et al. ACTA NEUROPATHOLOGICA
- Functional precision medicine identifies new therapeutic candidates for medulloblastoma
- (2020) Jessica M Rusert et al. CANCER RESEARCH
- Medulloblastoma
- (2019) Paul A. Northcott et al. Nature Reviews Disease Primers
- Data Sets for the Reporting of Tumors of the Central Nervous System
- (2019) David N. Louis et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- MiR-29b aggravates lipopolysaccharide-induced endothelial cells inflammatory damage by regulation of NF-κB and JNK signaling pathways
- (2018) Huifeng Yuan et al. BIOMEDICINE & PHARMACOTHERAPY
- The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastoma
- (2018) Michael Ehrhardt et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
- (2018) Evan F. Garner et al. Scientific Reports
- Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine
- (2018) Manendra Babu Lankadasari et al. Theranostics
- A biobank of patient-derived pediatric brain tumor models
- (2018) Sebastian Brabetz et al. NATURE MEDICINE
- Systemic treatment of pancreatic cancer revisited
- (2018) Michel Ducreux et al. SEMINARS IN ONCOLOGY
- The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival
- (2017) Eric M Thompson et al. NEURO-ONCOLOGY
- Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells
- (2017) D Kawauchi et al. ONCOGENE
- Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
- (2016) Vijay Ramaswamy et al. ACTA NEUROPATHOLOGICA
- MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties
- (2016) Sebastian Dietl et al. BMC CANCER
- DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets
- (2016) A. R. Hanaford et al. CLINICAL CANCER RESEARCH
- In vitro models of medulloblastoma: Choosing the right tool for the job
- (2016) Delyan P. Ivanov et al. JOURNAL OF BIOTECHNOLOGY
- Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer
- (2015) Igor M Bondarenko et al. BMC CANCER
- Multispectral Fluorescence Ultramicroscopy: Three-Dimensional Visualization and Automatic Quantification of Tumor Morphology, Drug Penetration, and Antiangiogenic Treatment Response
- (2015) Michael Dobosz et al. NEOPLASIA
- Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
- (2014) Torsten Pietsch et al. ACTA NEUROPATHOLOGICA
- Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma
- (2014) Marie Morfouace et al. CANCER CELL
- Pediatric Brain Tumor Cell Lines
- (2014) Jingying Xu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Medulloblastoma—translating discoveries from the bench to the bedside
- (2014) Amar J. Gajjar et al. Nature Reviews Clinical Oncology
- Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience
- (2013) Maura Massimino et al. CHILDS NERVOUS SYSTEM
- The rationale for targeted therapies in medulloblastoma
- (2013) Tobey J. MacDonald et al. NEURO-ONCOLOGY
- A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma
- (2012) Daisuke Kawauchi et al. CANCER CELL
- An Animal Model of MYC-Driven Medulloblastoma
- (2012) Yanxin Pei et al. CANCER CELL
- Mapping immune processes in intact tissues at cellular resolution
- (2012) Christian Brede et al. JOURNAL OF CLINICAL INVESTIGATION
- HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
- (2012) Till Milde et al. JOURNAL OF NEURO-ONCOLOGY
- Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
- (2011) Hedy L Kindler et al. LANCET ONCOLOGY
- Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study
- (2010) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- Axitinib—a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor
- (2009) Ronan J. Kelly et al. Targeted Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now